Company Profiles

driven by the PitchBook Platform

Avilex Pharma

Description

Operator of a biotechnology company for the treatment of ischemic strokes. The company provides dimeric peptides and medical drugs for the treatment of neuropathic pain and ischemic strokes.

2012

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$2.69M

Latest Deal Amount

$1.76M

Total Amount Raised

Description

Operator of a biotechnology company for the treatment of ischemic strokes. The company provides dimeric peptides and medical drugs for the treatment of neuropathic pain and ischemic strokes.

Website:

www.avilexpharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

Ole Maaløes Vej 3 København N 2200 CopenhagenDenmark +45 3533 6114
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Avilex Pharma's full profile, request a free trial.

    Avilex Pharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Avilex Pharma Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    NovoCorporate Venture CapitalMinority000 0000000 0000
    Wellcome TrustLimited Partner000 0000000 0000
    Novo Corporate Venture Capital
    Wellcome Trust Limited Partner

    Avilex Pharma Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Mark Treherne Ph.DChief Executive Officer
    Mikael Thomsen Ph.DChief Development Officer
    Kristian Stromgaard Ph.DCo-Founder & Chief Sales Officer
    Anders Bach Ph.DCo-Founder & Consultant
    Mark Treherne Ph.D Chief Executive Officer
    Mikael Thomsen Ph.D Chief Development Officer
    Kristian Stromgaard Ph.D Co-Founder & Chief Sales Officer
    Anders Bach Ph.D Co-Founder & Consultant

    Avilex Pharma Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Emmanuelle Coutanceau Ph.DNovoPrincipal, Novo Seeds000 0000
    Ingelise SaundersSelfChairman000 0000
    Nanna Luneborg Ph.DNovoPrincipal, Ventures000 0000
    Raymond Hill Ph.DSelfBoard Member000 0000
    Emmanuelle Coutanceau Ph.D Principal, Novo Seeds Novo
    Ingelise Saunders Chairman Self
    Nanna Luneborg Ph.D Principal, Ventures Novo
    Raymond Hill Ph.D Board Member Self
    Request full access to PitchBook